NeuroPace, Inc. has recently announced the appointment of Mr. Joel Becker as NeuroPace's President & CEO, effective July 10, 2023
Leadership Changes
June 29, 2023
NeuroPace, Inc., a medical device company dedicated to improving the lives of individuals with epilepsy, has recently announced the appointment of Mr. Joel Becker as NeuroPace's President & CEO, effective July 10, 2023. This strategic move comes as NeuroPace prepares for its next phase of commercial expansion and corporate development. Mr. Becker brings with him a wealth of experience in the medical technology industry.
Mr. Becker's appointment as President & CEO of NeuroPace signifies NeuroPace's commitment to growth and innovation. With over 25 years of experience in developing markets, driving growth, and leading medical technology companies, he is well-equipped to steer NeuroPace through its upcoming endeavors. His expertise spans diverse areas, from product development to corporate strategy and commercial execution, making him a valuable addition to the team.
NeuroPace Chairman of the Board of Directors, Frank Fischer, expressed gratitude towards outgoing CEO Mr. Michael Favet for his significant contributions to NeuroPace. Mr. Favet played a vital role in guiding NeuroPace through the challenges posed by the COVID-19 pandemic and successfully leading NeuroPace through an IPO process. While stepping down as CEO, Mr. Favet will continue to support NeuroPace as a consultant during the transition.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better trader.